Ely Benaim, MD

Has more than 25 years of experience in healthcare including 15 years of clinical research experience in academia, government and pharmaceutical industry as well as extensive experience in global regulatory affairs. Dr. Benaim was most recently Senior Vice President of Regulatory Affairs & Chief Medical Officer of Berg Pharma. Prior to joining Berg Pharma, Dr.…

Read More

John J. Rossi, PhD

Dr. John J. Rossi is an internationally recognized leader in the field of molecular biology. A pioneer in clinical research with nucleic acids and in the development of RNA-based therapies for human disease, Dr. Rossi was involved in the first human trials testing genetically altered stem cells for cancer therapy—work that has already led to the…

Read More

W. David Hardy, MD

W. David Hardy, M.D.

Serves as Adjunct Professor of Medicine, Division of Infectious Diseases at Johns Hopkins University School of Medicine and lives in Washington, D.C. He served as Senior Director of Evidence-based Practices (Research) at Whitman-Walker Health overseeing several NIH-funded clinical trial and HIV Cohort studies and industry-sponsored trials from 2015-2018. From 2002 to 2013 he served as…

Read More